{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:14:17Z","timestamp":1786371257748,"version":"build-2736575974"},"reference-count":39,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label\/><jats:p>Mpox has become the most significant orthopoxviral infection among humans. Since May 2022, there has been a multicountry outbreak of mpox across six continents. Retrospective observational cohort study of 94 patients with probable or confirmed mpox of whom 86.2% were hospitalized in Hospital for Infectious Diseases in Warsaw, Poland between May 16 and October 30, 2022. Most patients were young (median age: 31, IQR: 25\u221243 years), predominantly (88.3%) Polish men who have sex with men exposed most commonly in Poland (82.7%), Spain (6.2%), or Germany (4.9%). The median observed mpox incubation period was 7 (IQR: 4\u22128) days with the median hospitalization time of 7 (range: 2\u221224, IQR: 5\u221211) days. History of sexually transmitted infections (STIs) was common in the group (previous syphilis or hepatitis C virus in 33.3% and 17.3%, respectively, 6.2% of early syphilis or gonorrhea). A significant proportion (<jats:italic>n<\/jats:italic>\u2009=\u200943, 45.7%) of mpox cases were people with human immunodeficiency virus (HIV), all except one were on stable and virologically effective (88.4% with HIV viral load &lt;50 copies\/mL) antiretroviral treatment. Chemsex was reported in 34.6% of hospitalized cases, more commonly among people with HIV (48.5% vs. 25.0%, <jats:italic>p<\/jats:italic>\u2009=\u20090.029). None of the mpox infected patients presented with advanced HIV infection. Despite the fact that 6.3% of cases presented with &gt;50 skin lesions the course of the disease was self\u2010limited with no severe cases or deaths. There were no significant clinical or laboratory differences or complication rates between patients with and without HIV coinfection. Epidemiological and clinical characteristics of mpox in Poland are similar to other countries, but there were no targeted, population oriented interventions or vaccination programs. Mpox diagnosis provided an opportunity to screen and diagnose other STIs. As Central European populations, including refugees from Ukraine, are largely unvaccinated against mpox access to preventive vaccinations and antiviral therapy should be maximized.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jmv.29172","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T13:09:19Z","timestamp":1697807359000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparison of clinical course of Mpox among HIV\u2010negative and HIV\u2010positive patients: A 2022 cohort of hospitalized patients in Central Europe"],"prefix":"10.1002","volume":"95","author":[{"given":"Jacek","family":"Kowalski","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Collegium Medicum Cardinal Stefan Wyszy\u0144ski University Warsaw Poland"},{"name":"Hospital for Infectious Diseases Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Cielniak","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Collegium Medicum Cardinal Stefan Wyszy\u0144ski University Warsaw Poland"},{"name":"Hospital for Infectious Diseases Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Garbacz\u2010\u0141ago\u017cna","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Collegium Medicum Cardinal Stefan Wyszy\u0144ski University Warsaw Poland"},{"name":"Hospital for Infectious Diseases Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u017cyna","family":"Cholewi\u0144ska\u2010Szyma\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Collegium Medicum Cardinal Stefan Wyszy\u0144ski University Warsaw Poland"},{"name":"Hospital for Infectious Diseases Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi\u0142osz","family":"Parczewski","sequence":"additional","affiliation":[{"name":"Department of Infectious, Tropical Diseases and Immune Deficiency Pomeranian Medical University Szczecin Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010141"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01907-y"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001769"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28493"},{"key":"e_1_2_9_6_1","unstructured":"World Health Organization (WHO). WHO Director\u2010General's statement at the press conference following IHR Emergency Committee regarding the multi\u2010country outbreak of monkeypox.2022.https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-statement-on-the-press-conference-following-IHR-emergency-committee-regarding-the-multi-country-outbreak-of-monkeypox-23-july-2022"},{"key":"e_1_2_9_7_1","unstructured":"World Health Organization (WHO). Multi\u2010country outbreak of mpox external situation report.2023.https:\/\/www.who.int\/publications\/m\/item\/multi-country-outbreak-of-mpox--external-situation-report-25-24-june-2023"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit703"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix260"},{"key":"e_1_2_9_10_1","unstructured":"European Centre for Disease Prevention and Control (ECDC). Rapid risk assessment: monkeypox multi\u2010country outbreak. Stockholm: ECDC;2022.https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Monkeypox-multi-country-outbreak.pdf"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200424"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.27.2200471"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207323"},{"key":"e_1_2_9_14_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-072410","article-title":"Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series","volume":"378","author":"Patel A","year":"2022","journal-title":"BMJ"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01436-2"},{"key":"e_1_2_9_16_1","unstructured":"European Centre for Disease Prevention and Control (ECDC)\/World Health Organization Regional Office for Europe (WHO\/Europe). Monkeypox joint epidemiological overview. Stockholm and Copenhagen: ECDC and WHO\/Europe;2022.https:\/\/monkeypoxreport.ecdc.europa.eu\/"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.36.2200675"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00411-X"},{"issue":"22","key":"e_1_2_9_19_1","article-title":"Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel network: a cross\u2010sectional study","volume":"1473","author":"Angelo KM","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00273-8"},{"key":"e_1_2_9_21_1","unstructured":"Rainbow Europe map shows countries pushing forward with LGBTI rights as democracy is confronted.https:\/\/ilga-europe.org\/blog\/rainbow-europe-map-shows-countries-pushing-forward-with-lgbti-rights-as-democracy-is-confronted\/"},{"key":"e_1_2_9_22_1","unstructured":"European Centre for Disease Prevention and Control (ECDC). Public health considerations for mpox in EU\/EEA countries. Stockholm: ECDC;2023.https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Public%20health%20considerations%20for%20mpox%20in%20EUEEA%20countries%202023_0.pdf"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1086\/505880"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003271"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200421"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.28.2200503"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00513-8"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.7326\/M22-2183"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2810.221107"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00586-2"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7136a1"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13517"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30294-4"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28713"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12762"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.01.002"},{"key":"e_1_2_9_37_1","unstructured":"European Centre for Disease Prevention and Control (ECDC). Monkeypox multi\u2010country outbreak\u2014second update. Stockholm: ECDC;2022.https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Monkeypox-multi-country-outbreak-second-update.pdf"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11071781"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad151"},{"key":"e_1_2_9_40_1","unstructured":"AIDS Research National Institutes of Health. Clinicalinfo. guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV.https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-opportunistic-infection"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.29172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T12:35:33Z","timestamp":1722602133000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.29172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1002\/jmv.29172"],"URL":"https:\/\/doi.org\/10.1002\/jmv.29172","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"2023-07-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e29172"}}